Stocks › B › BPTH

Bio-Path Holdings, Inc. (BPTH) — Earnings Call X-Ray

Our AI read all 35 of BPTH's earnings calls (2016–2024) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q3 2024 · sign up to see
Previous Call Grade
D
Q2 2024
Expected Move
🔒
next 45 days · members
Calls Analyzed
35
2016–2024
Avg Candor
5.9/9
evasion 2.3/9
Promotional ToneCritic AmmunitionFounder-LedMargins ContractingReads RehearsedQuestion Left Hanging

Call-by-call analysis

🔒 Q3 2024 earnings call 2024-11-15 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor ■/9
Specificity ■/9
Evasion ■/9
Stress ■/9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q3 2024 call grade is ready
The full 37-point AI read of BPTH's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

D Q2 2024 earnings call 2024-08-15 move ±12.3%

Management gave no formal guidance against contracting margins. The delivery was promotional in tone.

Margins: contracting
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-led
Candor 5/9
Specificity 6/9
Evasion 0/9
Confidence 8/9
Uncertainty 3/9
Promotion 8/9
Stress 2/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q1 2024 earnings call 2024-05-15 move ±25.8%

Management gave no formal guidance against contracting margins. The delivery was promotional in tone.

Margins: contracting
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-ledDirection beats results
Candor 4/9
Specificity 6/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 8/9
Stress 2/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q4 2023 earnings call 2024-03-08 move ±25%

Management gave no formal guidance against contracting margins. The delivery was promotional in tone.

Margins: contracting 1 analysts · 3 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-ledDirection beats results
Candor 5/9
Specificity 6/9
Evasion 3/9
Confidence 8/9
Uncertainty 4/9
Promotion 8/9
Stress 2/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q3 2023 earnings call 2023-11-15 move ±22.5%

Management gave no formal guidance. The delivery was rich in specifics.

1 analysts · 5 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-ledDirection beats results
Candor 6/9
Specificity 7/9
Evasion 2/9
Confidence 7/9
Uncertainty 4/9
Promotion 6/9
Stress 4/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q2 2023 earnings call 2023-08-15 move ±33.1%

Management gave no formal guidance against contracting margins. The delivery was unusually candid, rich in specifics, visibly under pressure.

Margins: contracting 1 analysts · 4 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-ledDirection beats results
Candor 7/9
Specificity 7/9
Evasion 2/9
Confidence 8/9
Uncertainty 5/9
Promotion 8/9
Stress 6/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q1 2023 earnings call 2023-05-12 move ±12.4%

Management gave no formal guidance against contracting margins. The delivery was unusually candid.

Margins: contracting 1 analysts · 5 questions
⚑ Critic ammunition⚑ Question left hangingFounder-ledDirection beats results
Candor 7/9
Specificity 6/9
Evasion 3/9
Confidence 6/9
Uncertainty 6/9
Promotion 6/9
Stress 4/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q4 2022 earnings call 2023-03-31 move ±13.7%

Management gave no formal guidance against contracting margins. The delivery was unusually candid, rich in specifics.

Margins: contractingCapex: increasing 2 analysts · 5 questions
⚑ Critic ammunition⚑ Question left hangingFounder-ledDirection beats results
Candor 7/9
Specificity 7/9
Evasion 2/9
Confidence 7/9
Uncertainty 4/9
Promotion 6/9
Stress 3/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q3 2022 2022-11-15 F noneunclearcontracting 5/9 3/9
Q2 2022 2022-08-16 D noneunclearcontracting 6/9 3/9
Q1 2022 2022-05-17 D noneunclearcontracting 6/9 3/9
Q4 2021 2022-03-11 D noneunclearcontracting 6/9 3/9
Q3 2021 2021-11-12 D noneslowingunclear 7/9 2/9
Q2 2021 2021-08-13 F noneunclearunclear 6/9 5/9
Q1 2021 2021-05-14 D noneunclearcontracting 7/9 2/9
Q4 2020 2021-03-10 C+ noneunclearcontracting 7/9 2/9
Q3 2020 2020-11-13 F noneunclearcontracting 6/9 4/9
Q2 2020 2020-08-14 D noneunclearcontracting 6/9 2/9
Q1 2020 2020-05-15 D noneunclearcontracting 6/9 3/9
Q4 2019 2020-03-06 D noneunclearcontracting 6/9 3/9
Q3 2019 2019-11-15 D noneunclearcontracting 6/9 3/9
Q2 2019 2019-08-15 C noneunclearcontracting 6/9 2/9
Q1 2019 2019-05-16 D noneunclearunclear 6/9 2/9
Mar 2019 2019-03-20 D noneunclearcontracting 6/9 2/9
Q3 2018 2018-11-15 D noneunclearcontracting 4/9 0/9
Q2 2018 2018-08-15 D noneunclearunclear 6/9 2/9
Q1 2018 2018-05-16 D noneunclearunclear 6/9 2/9
Q4 2017 2018-04-03 D noneunclearcontracting 6/9 1/9
Q3 2017 2017-11-10 D noneunclearcontracting 6/9 2/9
Q2 2017 2017-08-10 F noneunclearunclear 5/9 4/9
Q1 2017 2017-05-11 C noneunclearunclear 6/9 1/9
Q4 2016 2017-03-15 C noneunclearcontracting 6/9 1/9
Q3 2016 2016-11-10 C noneunclearcontracting 6/9 1/9
Q2 2016 2016-08-10 C noneunclearcontracting 6/9 2/9
Q1 2016 2016-05-11 D noneunclearcontracting 6/9 2/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of BPTH's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

F Q2 2017 earnings call 2017-08-10

YES Answers go deeper than the script
19 more research questions answered NO
NO Compounding order flow
NO Customers eating the friction
NO Delivery mode: the call is about executing a specific step-up already in hand, not about winning it
NO Demand has broadened across independent fronts
NO Demand off the charts
NO Demand off the charts · scarcity_amplification_screen
NO Escape velocity out of a small base
NO First tranche delivered, larger tranches en route
NO Identified near-term contributors not yet in the reported numbers
NO Management is buying the same thing twice
NO New leadership already changing what the company does, with early results showing
NO Newly elevated priority replacing old playbook
NO senior hire recruited
NO Small reported base, oversized already-contracted forward commitments
NO Stale terms, scheduled reset
NO Structurally undersized shop with one oversized customer relationship it is now scaling into
NO Substance without an audience
NO The feared thing keeps not happening
NO The waiting list has become the product

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAC · AAC Holdings'AACAY · AAC Technologies HoldingAACG · ATA Creativity GlobalAADI · Aadi Bioscience, Inc.AALBF · Aalberts N.V.AAOI · Applied Optoelectronics,

← BPOSF   All “B” companies    BPY →

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.